Study of Serum Paraoxonase and High Density Lipoprotein Fractions in Diabetes

Authors

  • Arati Adhe-Rojekar DNB, Clinical Associate, Dept of IVF, PD Hinduja National Hospital & Research Center, Mahim Mumbai, India.
  • Mohit Vijay Rojekar Assistant Professor, Dept of Biochemistry, Rajiv Gandhi Medical College, Thane. India.
  • Mukund Ramchandra Mogarekar MD, Professor & Head, Dept of Biochemistry, SRTR Govt Medical College, Ambajogai. India.
Abstract:

Objective: Significant alteration in lipid profile and antioxidant system occurs in response to diabetes mellitus (DM). Paraoxonase (PON) is a family of three enzymes PON1, PON2 and PON3 associated with high density lipoprotein (HDL). The HDL in human plasma consists of two main sub-fractions HDL2C and HDL3C. We studied the HDL subclasses and HDL associated enzyme paraoxonase with respect to diabetes. Materials and Methods: The study was conducted in a tertiary care referral hospital in India. A total of 80 subjects were included in the study. Lipid profile, PON1 arylesterase (ARE), PON1 lactonase (LACT) and HDL fractions were estimated. Regression analysis was applied. Results: PON1 ARE, LACT and HDL fractions are found to be decreased among cases than in controls. PON1 ARE & LACT showed negative correlation with blood glucose levels and HDL 3C while positive correlation with HDL 2C. Conclusion: PON1 ARE and PON1 LACT activities reduction are due to increased oxidative stress. PON1 as well as HDL fraction levels are oxidative stress subjects. Among the HDL fractions, HDL2C is the more variable fraction and reflects changes in HDL. The study suggested that the protective role of total HDL against oxidative damage and complications is mainly mediated through HDL2C fraction.  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

High -density lipoprotein cholesterol as a predictor for diabetes mellitus

Background: Diabetes is a prevalent chronic disease around the world. To evaluate risk of diabetes comprehensively, we developed a score model for the risk prediction with HDL-C as a protective factor. Methods: We extracted physical examination data of 2728 individuals. The data contain 18 demographic and clinical variables. To identify the statistical significant feature variables, the backwa...

full text

High density lipoprotein subfractions and paraoxonase 1 in children.

The Lipoprint system (Quantimetrix Corp., CA, USA), enables the determination of 10 high density lipoprotein (HDL) subfractions in contrast to the 5 HDL subfractions that can be determined by ultracentrifuge analysis. HDL subfractions, and their relationships to the arylesterase (PON1-A) and lactonase (PON1-L) activities of paraoxonase 1 (PON1), together with total-, very low density lipoprotei...

full text

High-density lipoprotein composition and paraoxonase activity in Type I diabetes.

Type I diabetes is associated with a high incidence of coronary heart disease (CHD), despite a normal or even increased concentration of high-density lipoprotein (HDL) cholesterol. This paradox may be explained by changes in the antioxidant capacity of HDL, related to paraoxonase (PON1) activity. HDL compositional changes in subjects with Type I diabetes may result in changes in PON1 activity t...

full text

Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity

BACKGROUND High density lipoprotein (HDL) particles are heterogeneous in composition, structure, size, and may differ in conferring protection against cardiovascular disease. HDL associated enzyme, paraoxonase-1 (PON1), has an important role in attenuation of atherogenic low density lipoprotein (LDL) oxidation. The aim of this study was to investigate the associations between HDL particle size ...

full text

Protective Effect of High Density Lipoprotein Associated Paraoxonase

Introduction Our group has previously demonstrated that oxidized phospholipids in mildly oxidized LDL (MM-LDL) produced by oxidation with lipoxygenase, iron, or cocultures of artery wall cells increase monocyte-endothelial interactions and this sequence of events is blocked by HDL. To obtain further insight into the mechanism by which HDL abolishes the activity of MM-LDL we investigated the eff...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 10  issue 1

pages  16- 22

publication date 2018-03

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023